Bruker AVANCE IVDr High-Performance, High-Throughput In Vitro Diagnostic NMR Platform

Overview

The Bruker AVANCE IVDr is a purpose-built, standardized nuclear magnetic resonance (NMR) platform engineered exclusively for high-throughput in vitro diagnostic (IVD) research and preclinical screening. Unlike conventional benchtop or low-field NMR systems, the AVANCE IVDr operates at 600 MHz ¹H frequency—delivering superior spectral resolution, chemical shift dispersion, and quantitative reproducibility essential for robust biomarker discovery and clinical assay development. Its architecture integrates high-sensitivity cryoprobes, ultra-stable field homogeneity, and digital signal processing optimized for biological fluids (e.g., serum, plasma, urine, CSF), enabling simultaneous quantification of >50 endogenous metabolites with sub-micromolar precision. Designed strictly for research use—not clinical deployment—the system complies with ISO/IEC 17025 principles for testing laboratories and supports GLP-aligned workflows through traceable calibration, audit-ready metadata logging, and instrument qualification documentation.

Key Features

• 600 MHz ¹H operating frequency with actively shielded wide-bore magnet and cryogen-free or liquid helium-cooled probe options
• SampleJet™ high-throughput autosampler supporting up to 96 samples per run with barcode scanning and LIMS integration (via ASTM E1578-compliant interface)
• Pre-validated, SOP-driven acquisition and processing workflows—including pulse sequence libraries (e.g., CPMG, NOESY, J-resolved), automated phasing/baseline correction, and absolute quantification using internal standards (e.g., DSS, TSP)
• Bruker’s IVDr Biofluid Analysis Suite (BAS) software with embedded spectral libraries (Human Metabolome Database–compatible), statistical modeling tools (PCA, PLS-DA), and customizable reporting templates compliant with FDA 21 CFR Part 11 requirements for electronic records and signatures
• Remote operation capability via secure HTTPS-based web interface with real-time status monitoring, queue management, and encrypted data transfer
• Full IQ/OQ/PQ documentation package available for laboratory validation under GxP frameworks

Sample Compatibility & Compliance

The AVANCE IVDr accepts standard 5 mm NMR tubes (e.g., Wilmad 528-PP) and is validated for human biofluids requiring minimal sample preparation: deproteinized serum/plasma (e.g., methanol/chloroform extraction), centrifuged urine, and filtered cerebrospinal fluid. All SOPs are developed in alignment with ISO 13528 (statistical methods for proficiency testing) and CLSI EP28-A3c (defining analytical performance for clinical assays). While not CE-IVD or FDA 510(k)-cleared, the platform meets technical prerequisites for IVD assay development per ISO 15189:2022 (medical laboratories—requirements for quality and competence) and supports method transfer across multi-site epidemiological studies under harmonized protocols.

Software & Data Management

Data acquisition, processing, and reporting are unified within TopSpin 4.2+ and IVDr BAS v3.x. Raw FID files are stored in Bruker’s proprietary format (with ASCII export options) and tagged with ISO/IEC 11179-compliant metadata (sample ID, operator, timestamp, instrument conditions, calibration status). Audit trails record all user actions—including parameter edits, reprocessing events, and report generation—with immutable timestamps and role-based access control. Export formats include CSV, PDF/A-2b (for long-term archiving), and mzML-compatible spectral tables for cross-platform metabolomics integration. Data integrity is reinforced via SHA-256 checksums and optional integration with enterprise LIMS (e.g., LabVantage, Thermo Fisher SampleManager) using HL7 or RESTful APIs.

Applications

• Large-scale population metabolomics in prospective cohort studies (e.g., UK Biobank, EPIC)
• Development and analytical validation of NMR-based IVD assays for metabolic disorders (e.g., diabetes subtyping), cardiovascular risk stratification, and oncology monitoring
• Preclinical toxicology screening assessing drug-induced metabolic perturbations in rodent biofluids
• Reference method establishment for mass spectrometry cross-validation under ISO/IEC 17043 proficiency testing schemes
• Multi-center biomarker qualification studies requiring inter-laboratory reproducibility (CV 10 sites)

FAQ

Is the AVANCE IVDr approved for clinical diagnostics use?

No. It is designated solely for research purposes and is not cleared or approved by regulatory authorities (e.g., FDA, CE-IVD) for diagnostic decision-making.
Can the system be integrated into existing laboratory IT infrastructure?

Yes—via standard network protocols (DICOM, HL7, REST API), LIMS middleware, and secure SFTP for automated data ingestion and reporting.
What level of technical support and training is provided?

Bruker offers on-site installation qualification, SOP customization workshops, and annual competency assessments aligned with ISO/IEC 17025 staff training requirements.
Does the platform support method transfer between laboratories?

Yes—pre-qualified SOPs, hardware benchmarking reports, and inter-laboratory reproducibility data packages are included to facilitate multi-site assay harmonization.
Are consumables and maintenance services covered under service agreements?

Comprehensive service contracts include preventive maintenance, cryogen replenishment (if applicable), software updates, and priority remote diagnostics—all documented per ISO 9001:2015 quality management standards.